fda update on semaglutide 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these Vitality Medical | Big update

Enjoy Episodes #58 and #59 discussing constrictive pericarditis

Curious about GLP-1 weight loss

The review followed established quality guidance for narrative synthesis and was structured using the PopulationConceptContext framework to improve transparency in the selection and synthesis of the literature

regulators flagged severe and sometimes fatal pancreatitis cases in 2007-2008 for the earlier GLP-1 drug Byetta (exenatide) and advised clinicians to stop therapy if patients develop persistent severe abdominal pain radiating to the back In the United States, nearly 2,000 GLP-1 lawsuitsprimarily alleging severe gastrointestinal injuries (gastroparesis, bowel obstruction, related complications) after Ozempic, Wegovy, Mounjaro, Trulicity, and other agentsare centralized in federal Multidistrict Litigation (MDL No

Thus, these lines of evidence suggest that the widespread antimicrobial activity of this drug can be ascribed, at least in part, to the potentiation of the host innate immunity

Diabetes mellitus is a lifelong condition in which the body cannot properly use or make insulin the hormone that helps blood sugar (glucose) enter your cells for energy